What Has Been The Evolution of the Single Use Bioprocessing Market in Recent Years?
The single use bioprocessing market has seen considerable growth due to a variety of factors.
• The market size for single use bioprocessing has seen swift growth in the past few years. The market, which was worth $26.87 billion in 2024, is predicted to rise to $32.02 billion in 2025, showcasing a compound annual growth rate (CAGR) of 19.2%.
The historic growth can be ascribed to factors such as biopharmaceutical manufacturing, biotechnology and cell culture methods, a decrease in risks related to cross-contamination, compliance with bioprocessing regulations, and a rising demand for affordable solutions.
What Is the Forecasted Market Size and Growth Rate for The Single Use Bioprocessing Market?
The single use bioprocessing market is expected to maintain its strong growth trajectory in upcoming years.
• In the approaching years, the market size for single use bioprocessing is projected to experience significant growth, reaching a value of $68.6 billion in 2029, with a compound annual growth rate (CAGR) of 21.0%.
This projected expansion within the forecast period can be attributed to multiple factors including the growth of personalized medicine, the production of gene and cell therapy, the adoption of continuous bioprocessing, biomanufacturing for uncommon diseases, and the evolution of biosafety levels. More so, emerging markets and global biomanufacturing hubs play a major role. Several trends to watch in the forecast period are automated and robotic single-use systems, single-use sensors and analytics, aseptic filling and packaging within a closed system, modular and scalable bioprocessing facilities, on-demand and decentralized biomanufacturing, alongside virus filtration and purification solutions.
What Are The Core Factors Supporting Growth In The Single Use Bioprocessing Market?
The growth of the single-use bioprocessing market is set to be fuelled by the rising demand for biopharmaceuticals. These medicines, derived from living cells or organisms, are frequently manufactured using single-use bioprocessing systems to enhance productivity, minimise costs, and ensure safe waste disposal. For instance, data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), an organization based in Belgium, representing the pharmaceutical sector, indicates a significant spike in the production by the European pharmaceutical industry in June 2023. Production increased from $352.48 billion in 2021 to $369.95 billion in 2022. This escalating demand for biopharmaceuticals is a key factor driving expansion in the single-use bioprocessing market.
What Are The Major Segments Within The Global Single Use Bioprocessing Market?
The single use bioprocessing market covered in this report is segmented –
1) By Product: Single-Use Media Bags And Containers, Single-Use Assemblies, Single-Use Bioreactors, Disposable Mixers, Other Products
2) By Workflow: Upstream, Fermentation, Downstream
3) By Application: Filtration, Storage, Cell Culture, Mixing, Purification
4) By End User: Biopharmaceutical And Pharmaceutical companies, Contract Research Organizations And Contract Manufacturing Organizations (CROs and CMOs), Academic and Research institutes
Subsegments:
1) By Single-Use Media Bags and Containers: Media Bags, Storage Containers, Transport Bags
2) By Single-Use Assemblies: Preassembled Kits, Tubing Sets, Connector Assemblies
3) By Single-Use Bioreactors: Stirred-Tank Bioreactors, Wave-Mixed Bioreactors, Other Bioreactor Types
4) By Disposable Mixers: Single-Use Stirring Devices, Single-Use Agitators
5) By Other Products: Filtration Devices, Sampling Devices, Accessories
Pre-Book The Single Use Bioprocessing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Trends Are Expected To Transform The Single Use Bioprocessing Market?
One major trend in the single-use bioprocessing market that is gaining traction is the advancement in technology. Leading companies are embracing computer technologies to maintain their competitive edge in the market. For example, in April 2023, the American company Cytiva launched X-platform bioreactors specifically designed to boost effectiveness in single-use upstream bioprocessing. The bioreactors, initially offered in sizes ranging from 50 to 200 liters, were furnished with the Figurate automation solution software. They are designed with the aim of enhancing process efficiency, increasing production capacity, improving ergonomic design, and optimizing supply chain operations.
Who Are the Key Players in the Single Use Bioprocessing Market?
Major companies operating in the single use bioprocessing market include:
• GE Healthcare Technologies Ltd.
• Eppendorf AG
• Corning Incorporated
• Thermo Fisher Scientific Inc.
• Sartorius AG
• JM BioConnect BV
• Merck KGaA
• Pall Corporation
• Kuhner AG
• PBS Biotech Inc.
• Entegris Inc.
• DistriCell Inc.
• ABEC Inc.
• Able Corporation and Biott Corporation
• Solida Biotech GmbH
• OmniBRx Biotechnologies Pvt. Ltd.
• Satake Chemical Equipment Mfg. Co. Ltd.
• Stobbe Pharma GmbH
• Celltainer Biotech BV
• Cellexus BV
• Danaher Corporation
• Boehringer Ingelheim International GmbH
• General Electric Company
• Rentschler Biopharma SE
• Repligen Corporation
• Sollesis Medical Plc
• Charter Medical Inc.
• Secant Group LLC
• Lonza Group Ltd.
• Hoffmann-La Roche Ltd.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Sanofi S.A.
• Pfizer Inc.
• Catalent Inc.
• Patheon Inc.
• Bio-Rad Laboratories Inc.
• Avantor Performance Materials India Limited
• MilliporeSigma
• Saint-Gobain Performance Plastics Corp.
• Meissner Filtration Products Inc.
What Is The Most Dominant Region In The Single Use Bioprocessing Market?
North America was the largest region in the single-use bioprocessing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single use bioprocessing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
